Results 41 to 50 of about 1,983,235 (163)
Objective: The use of ureteral catheters in renal transplantation is controversial. We aimed to investigate the effect of intraoperative catheter use on bacteriuria and urological complications in deceased donor renal transplantation. Material and Method:
Bahar Canbay Torun +3 more
doaj +1 more source
The Anti-thymocyte Globulin use makes kidney transplantation journey smooth
Background: The most common immunosuppressant, Anti-thymocyte Globulin (ATGs) has been widely used by clinicians for the treatment and prevention of rejection at the time of organ transplant.
Akbar Mahmood Sultan +4 more
doaj +1 more source
The Combination of Anti-Thymocyte Globulin and Basiliximab for Haploidentical Hematopoietic Stem Cell Transplantation [PDF]
Objectives: Identical hematopoietic stem cell transplantation (haplo-HSCT) is associated with a higher risk of graft rejection when compared to matched sibling donor transplantations.
Luo, Yun +8 more
core +1 more source
Objective: To investigate the correlation between total lymphocyte and CD3+ T cell counts in peripheral blood in renal transplant patients treated with anti-thymocyte globulin, and discuss related outcomes.
Fabiani Palagi Machado +4 more
doaj +1 more source
Background: In our population, anti-thymocyte globulin (ATG) of 1 mg/Kg/day for 4 days is used; which permits not using valgancyclovir (VGC) prophylaxis in some renal transplant recipients (RTR) with moderate risk (R+), to reduce costs.
Jorge Andrade-Sierra +12 more
doaj +1 more source
Living donor heart valves offer superior durability for pediatric patients but trigger immune rejection. Lentiviral delivery of viral immune‐evasion genes US2 and Serpin b9 into donor valve cells and valve tissue suppresses HLA expression, reduces PBMC clustering and cytotoxic killing, and induces transcriptional immune‐tolerance programs, paving the ...
Abraham van Wijk +11 more
wiley +1 more source
ABSTRACT Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is a potentially curative strategy for acute myeloid leukemia (AML), but the impact of HLA disparity in the era of posttransplant cyclophosphamide (PTCy) and reduced‐toxicity conditioning remains unclear. We performed an EBMT registry study including 275 adult AML patients in first
Daniele Avenoso +21 more
wiley +1 more source
Not required for Clinical Vignette.
Maria Świerkot +5 more
doaj +1 more source
ABSTRACT Posttransplant cyclophosphamide (PTCy) to prevent graft‐versus‐host disease (GVHD) improves outcomes in recipients of HLA mismatched unrelated donor (MMUD) allogeneic hematopoietic cell transplantation (allo HCT). Outcomes of MMUD HCT using PTCy in patients requiring reduced intensity or non‐myeloablative conditioning (RIC/NMA) are not well ...
Brian C. Shaffer +38 more
wiley +1 more source
Supplemental Material for Myeloid-derived suppressor cells are bound and inhibited by anti-thymocyte globulin by Young Suk Lee, Eduardo Davila, Tianshu Zhang, Hugh P Milmoe, Stefanie N Vogel, Jonathan S Bromberg and Joseph R Scalea in Innate ...
Stefanie N Vogel (6246032) +6 more
core +1 more source

